TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | 4 | 12 | 14 | -10 | 0 | 4 |
| S | %wins | 33 | 33 | 0 | 0 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/16 12:32 | 7/8/16 | ICCC | Immucell Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crabb Joseph H | ME | DO | VP,Chief | S | -13 | 6.55 | 0 | -2 | -2 | 105 | D | 46 | -24 | -13 | 3 | 2 | -2 | -4 | 5 | 1 | 0 | 16 | 9 | -12 | |
7/7/16 16:46 | 7/6/16 | ICCC | Immucell Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crabb Joseph H | ME | DO | VP,Chief | S.m | -18 | 6.58 | 0 | -3 | -2 | 107 | D | 44 | -16 | -11 | -2 | -3 | -5 | -8 | -4 | 4 | 6 | 12 | 19 | -8 | |
7/6/16 09:42 | 7/1/16 | ICCC | Immucell Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Crabb Joseph H | ME | DO | VP,CSO | S.m | -36 | 6.74 | 0 | -5 | -2 | 223 | D | 50 | -16 | -10 | -3 | 0 | -4 | -6 | -8 | -1 | 5 | 8 | 15 | -11 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |